臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liou j m"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 391-415 / 639 (共26頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-02-02T02:21:23Z	Development of bacterial transglycosylase inhibitors as new antibiotics: Moenomycin A treatment for drug-resistant Helicobacter pylori	Tseng Y.-Y.; Liou J.-M.; Hsu T.-L.; Cheng W.-C.; MING-SHIANG WU; Wong C.-H.
臺大學術典藏	2021-02-02T02:21:22Z	Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; MING-SHIANG WU; Liou J.-M.; Tsai H.-J.; Tzeng Y.-S.; Cheng A.-L.
臺大學術典藏	2021-02-02T02:21:21Z	Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan	Cheng A.; Sheng W.-H.; Liou J.-M.; Wang H.-P.; MING-SHIANG WU; Lin J.-T.; Chang S.-C.
臺大學術典藏	2021-02-02T02:21:19Z	The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study	Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:21:18Z	Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance	Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; Liou J.-M.; MING-SHIANG WU; Chang W.-L.; Wu C.-Y.; Lin J.-T.
臺大學術典藏	2021-02-02T02:21:17Z	Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease	Tseng P.-H.; Yang W.-S.; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:17Z	Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria	Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:15Z	Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects	Liou J.-M.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:15Z	Mass eradication of helicobacter pylori to prevent gastric cancer: Theoretical and practical considerations	Lee Y.-C.; Chiang T.-H.; Liou J.-M.; Chen H.-H.; MING-SHIANG WU; Graham D.Y.
臺大學術典藏	2021-02-02T02:21:15Z	Statins and the risk of pancreatic cancer in Type 2 diabetic patients - A population-based cohort study	Chen M.-J.; Tsan Y.-T.; Liou J.-M.; Lee Y.-C.; MING-SHIANG WU; Chiu H.-M.; Wang H.-P.; Chen P.-C.
臺大學術典藏	2021-02-02T02:21:14Z	Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection	Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:14Z	Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial	Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:13Z	letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? Authors' reply	Liou J.-M.; Chen M.-J.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:13Z	Massive left pleural effusion after endoscopic variceal therapy	Wu W.-K.; Wang H.-P.; Liou J.-M.; MING-SHIANG WU; Chen Y.-T.
臺大學術典藏	2021-02-02T02:21:10Z	Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection	Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:21:09Z	Reply to Kim J.S. and Kim B.-W.	Liou J.-M.; Chang C.-Y.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:08Z	Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial	Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:21:08Z	Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial	Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:21:07Z	Treatment of Helicobacter pylori infection: Where are we now?	Liou J.-M.; MING-SHIANG WU; Lin J.-T.
臺大學術典藏	2021-02-02T02:21:06Z	Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL	Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; Liou J.-M.; MING-SHIANG WU; Hsu P.-N.; Cheng A.-L.
臺大學術典藏	2021-02-02T02:21:06Z	The Impact of Gastric Atrophy on the Incidence of Diabetes	Yu T.-Y.; Wei J.-N.; Kuo C.-H.; Liou J.-M.; Lin M.-S.; Shih S.-R.; Hua C.-H.; Hsein Y.-C.; Hsu Y.-W.; Chuang L.-M.; Lee M.-K.; Hsiao C.-H.; MING-SHIANG WU; Li H.-Y.
臺大學術典藏	2021-02-02T02:21:06Z	Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?	Liou J.-M.; Lin J.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:05Z	Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer	Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU
臺大學術典藏	2021-02-02T02:21:04Z	letter: levofloxacin resistance – a challenge for treatment of Helicobacter pylori infection. Authors' reply	Chen P.-Y.; MING-SHIANG WU; Liou J.-M.
臺大學術典藏	2021-02-02T02:21:03Z	Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale	Sheu B.-S.; MING-SHIANG WU; Chiu C.-T.; Lo J.-C.; Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.

顯示項目 391-415 / 639 (共26頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51992985 線上人數 : 804 教育部委託研究計畫計畫執行:國立臺灣大學圖書館